Passage Bio Stock Probability of Future Stock Price Finishing Over 1.5
| PASG Stock | USD 0.83 0.26 45.61% |
Passage |
Passage Bio Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Passage Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Passage Bio can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Passage Bio is way too risky over 90 days horizon | |
| Passage Bio has some characteristics of a very speculative penny stock | |
| Passage Bio appears to be risky and price may revert if volatility continues | |
| Passage Bio has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (102.06 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Passage Bio currently holds about 239.25 M in cash with (78.26 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.39, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Passage Bio has a frail financial position based on the latest SEC disclosures | |
| Roughly 60.0% of the company shares are owned by institutional investors |
Passage Bio Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Passage Stock often depends not only on the future outlook of the current and potential Passage Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Passage Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 54.7 M | |
| Cash And Short Term Investments | 114.3 M |
Passage Bio Technical Analysis
Passage Bio's future price can be derived by breaking down and analyzing its technical indicators over time. Passage Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Passage Bio. In general, you should focus on analyzing Passage Stock price patterns and their correlations with different microeconomic environments and drivers.
Passage Bio Predictive Forecast Models
Passage Bio's time-series forecasting models is one of many Passage Bio's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Passage Bio's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Passage Bio
Checking the ongoing alerts about Passage Bio for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Passage Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Passage Bio is way too risky over 90 days horizon | |
| Passage Bio has some characteristics of a very speculative penny stock | |
| Passage Bio appears to be risky and price may revert if volatility continues | |
| Passage Bio has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (102.06 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Passage Bio currently holds about 239.25 M in cash with (78.26 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.39, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Passage Bio has a frail financial position based on the latest SEC disclosures | |
| Roughly 60.0% of the company shares are owned by institutional investors |
Check out Passage Bio Backtesting, Passage Bio Valuation, Passage Bio Correlation, Passage Bio Hype Analysis, Passage Bio Volatility, Passage Bio History as well as Passage Bio Performance. For more detail on how to invest in Passage Stock please use our How to Invest in Passage Bio guide.You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Passage Bio. If investors know Passage will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Passage Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Passage Bio is measured differently than its book value, which is the value of Passage that is recorded on the company's balance sheet. Investors also form their own opinion of Passage Bio's value that differs from its market value or its book value, called intrinsic value, which is Passage Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Passage Bio's market value can be influenced by many factors that don't directly affect Passage Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Passage Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Passage Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Passage Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.